产品名称
3′-Hydroxystanozolol-D3, vial of 5 mg, certified reference material, Cerilliant®
InChI
1S/C21H32N2O2/c1-19-11-14-17(22-23-18(14)24)10-12(19)4-5-13-15(19)6-8-20(2)16(13)7-9-21(20,3)25/h12-13,15-16,25H,4-11H2,1-3H3,(H2,22,23,24)/t12-,13?,15?,16?,19-,20-,21-/m0/s1/i3D3
InChI key
SWPAIUOYLTYQKK-XALPJPGDSA-N
SMILES string
OC1=NNC2=C1C[C@@]3(C)[C@](CCC4C3CC[C@@]5(C)C4CC[C@@]5(O)C([2H])([2H])[2H])([H])C2
grade
certified reference material
packaging
vial of 5 mg
manufacturer/tradename
Cerilliant®
drug control
regulated under CDSA - not available from Sigma-Aldrich Canada
format
neat
storage temp.
−20°C
Quality Level
General description
3′-Hydroxystanozolol is a major urinary metabolite of stanozolol, an anabolic androgenic steroid. Stanozolol is used as a treatment for osteoporosis and steroid-deficiency but has also been abused in sports as a performance-enhancing drug. This internal standard is suitable for quantitation of 3′-Hydroxystanozolol levels in urine, serum, or plasma by LC/MS or GC/MS for sports testing, urine drug testing, or forensic analysis.
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
hcodes
Hazard Classifications
Carc. 2 - Repr. 1B
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持